AAAAAA

   
Results: 1-11 |
Results: 11
HLA-DR ALLELES PREDICTIVE FOR NONRESPONSIVENESS TO INTERFERON-ALPHA TREATMENT IN CHRONIC HEPATITIS-C INFECTION
Authors: KOSKIMIES S EBELING F FARKKILA M VUORISTO M NUUTINEN H LEINO R KARVONEN AL LEHTOLA J JULKUNEN R LAPPALAINEN M POHIANPELTO P
Citation: S. Koskimies et al., HLA-DR ALLELES PREDICTIVE FOR NONRESPONSIVENESS TO INTERFERON-ALPHA TREATMENT IN CHRONIC HEPATITIS-C INFECTION, Hepatology, 28(4), 1998, pp. 189-189
EFFICACY OF NATURAL LEUKOCYTE INTERFERON-ALPHA IN CHRONIC HEPATITIS-C- AN ONGOING STUDY
Authors: EBELING F FARKKILA M VUORISTO M NUUTINEN H LEINO R KARYONEN AL LEHTOLA J JULKUNEN R LAPPALAINEN M POHJANPELTO P
Citation: F. Ebeling et al., EFFICACY OF NATURAL LEUKOCYTE INTERFERON-ALPHA IN CHRONIC HEPATITIS-C- AN ONGOING STUDY, Hepatology, 28(4), 1998, pp. 2122-2122
FREE IRON DURING BONE-MARROW TRANSPLANTATION
Authors: SAHLSTEDT L EBELING F PARKKINEN J VONBONSDORFF L MYLLYLA G RUUTU T
Citation: L. Sahlstedt et al., FREE IRON DURING BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 327-327
EPIDEMIOLOGY OF THE HEPATITIS-C VIRUS
Authors: EBELING F
Citation: F. Ebeling, EPIDEMIOLOGY OF THE HEPATITIS-C VIRUS, Vox sanguinis, 74, 1998, pp. 143-146
NO PREVENTION OF CYTOMEGALOVIRUS-INFECTION BY ANTICYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN IN SERONEGATIVE BONE-MARROW TRANSPLANT RECIPIENTS
Authors: RUUTU T LJUNGMAN P BRINCH L LENHOFF S LONNQVIST B RINGDEN O RUUTU P VOLIN L ALBRECHTSEN D SALLERFORS B EBELING F MYLLYLA G
Citation: T. Ruutu et al., NO PREVENTION OF CYTOMEGALOVIRUS-INFECTION BY ANTICYTOMEGALOVIRUS HYPERIMMUNE GLOBULIN IN SERONEGATIVE BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 19(3), 1997, pp. 233-236
RADIOFREQUENCY CATHETER ABLATION OF AN AC CESSORY PATHWAY WITH PERSISTENT LEFT SUPERIOR VENA-CAVA AND HYPERTROPHIC CARDIOMYOPATHY
Authors: NEUSER H HOFMANN E EBELING F REMP T STEINBECK G
Citation: H. Neuser et al., RADIOFREQUENCY CATHETER ABLATION OF AN AC CESSORY PATHWAY WITH PERSISTENT LEFT SUPERIOR VENA-CAVA AND HYPERTROPHIC CARDIOMYOPATHY, Zeitschrift fur Kardiologie, 85(8), 1996, pp. 596-602
HEPATITIS-E VIRUS - NO EVIDENCE OF PARENTERAL TRANSMISSION IN FINLAND
Authors: POHJANPELTO P EBELING F RASI V HAMPL H
Citation: P. Pohjanpelto et al., HEPATITIS-E VIRUS - NO EVIDENCE OF PARENTERAL TRANSMISSION IN FINLAND, Thrombosis and haemostasis, 74(5), 1995, pp. 1385-1386
TOLERABILITY AND KINETICS OF A SOLVENT-DETERGENT-TREATED INTRAVENOUS IMMUNOGLOBULIN PREPARATION IN HYPOGAMMAGLOBULINEMIA PATIENTS
Authors: EBELING F BAER M HORMILA P JARVENTIE G KOISTINEN P KATKA K OKSANEN K PERKKIO M RUUTU T SOPPI E VEIJOLA L MYLLYLA G
Citation: F. Ebeling et al., TOLERABILITY AND KINETICS OF A SOLVENT-DETERGENT-TREATED INTRAVENOUS IMMUNOGLOBULIN PREPARATION IN HYPOGAMMAGLOBULINEMIA PATIENTS, Vox sanguinis, 69(2), 1995, pp. 91-94
APOLIPOPROTEIN-E POLYMORPHISM, SERUM-LIPIDS, MYOCARDIAL-INFARCTION AND SEVERITY OF ANGIOGRAPHICALLY VERIFIED CORONARY-ARTERY DISEASE IN MENSIND WOMEN
Authors: LEHTINEN S LEHTIMAKI T SISTO T SALENIUS JP NIKKILA M JOKELA H KOIVULA T EBELING F EHNHOLM C
Citation: S. Lehtinen et al., APOLIPOPROTEIN-E POLYMORPHISM, SERUM-LIPIDS, MYOCARDIAL-INFARCTION AND SEVERITY OF ANGIOGRAPHICALLY VERIFIED CORONARY-ARTERY DISEASE IN MENSIND WOMEN, Atherosclerosis, 114(1), 1995, pp. 83-91
ADVERSE REACTIONS TO PLATELET TRANSFUSIONS ARE REDUCED BY USE OF PLATELET CONCENTRATES DERIVED FROM BUFFY COAT
Authors: OKSANEN K EBELING F KEKOMAKI R ELONEN E SAHLSTEDT L VOLIN L MYLLYLA G
Citation: K. Oksanen et al., ADVERSE REACTIONS TO PLATELET TRANSFUSIONS ARE REDUCED BY USE OF PLATELET CONCENTRATES DERIVED FROM BUFFY COAT, Vox sanguinis, 67(4), 1994, pp. 356-361
NO EVIDENCE FOR HAV TRANSMISSION THROUGH COAGULATION-FACTOR CONCENTRATES IN FINNISH HEMOPHILIACS
Authors: EBELING F RASI V MYLLYLA G
Citation: F. Ebeling et al., NO EVIDENCE FOR HAV TRANSMISSION THROUGH COAGULATION-FACTOR CONCENTRATES IN FINNISH HEMOPHILIACS, Vox sanguinis, 67, 1994, pp. 36-37
Risultati: 1-11 |